  The emergence of multi-parametric magnetic resonance imaging (mpMRI) has had
a profound impact on the diagnosis of prostate cancers (PCa), which is the most
prevalent malignancy in males in the western world, enabling a better selection
of patients for confirmation biopsy. However, analyzing these images is complex
even for experts, hence opening an opportunity for computer-aided diagnosis
systems to seize. This paper proposes a fully automatic system based on Deep
Learning that takes a prostate mpMRI from a PCa-suspect patient and, by
leveraging the Retina U-Net detection framework, locates PCa lesions, segments
them, and predicts their most likely Gleason grade group (GGG). It uses 490
mpMRIs for training/validation, and 75 patients for testing from two different
datasets: ProstateX and IVO (Valencia Oncology Institute Foundation). In the
test set, it achieves an excellent lesion-level AUC/sensitivity/specificity for
the GGG$\geq$2 significance criterion of 0.96/1.00/0.79 for the ProstateX
dataset, and 0.95/1.00/0.80 for the IVO dataset. Evaluated at a patient level,
the results are 0.87/1.00/0.375 in ProstateX, and 0.91/1.00/0.762 in IVO.
Furthermore, on the online ProstateX grand challenge, the model obtained an AUC
of 0.85 (0.87 when trained only on the ProstateX data, tying up with the
original winner of the challenge). For expert comparison, IVO radiologist's
PI-RADS 4 sensitivity/specificity were 0.88/0.56 at a lesion level, and
0.85/0.58 at a patient level. Additional subsystems for automatic prostate
zonal segmentation and mpMRI non-rigid sequence registration were also employed
to produce the final fully automated system. The code for the ProstateX-trained
system has been made openly available at
https://github.com/OscarPellicer/prostate_lesion_detection. We hope that this
will represent a landmark for future research to use, compare and improve upon.
